Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Advanced Search

Search

You could also try: daily (649)

Bulevirtide (Hepcludex®) for the treatment of chronic hepatitis D - patient information

Description: This factsheet explains what bulevirtide (Hepcludex®) is, how it is given to treat hepatitis D and the possible side effects.
Url: /Media/UHS-website-2019/Patientinformation/Digestionandurinaryhealth/Hepatology/Bulevirtide-Hepcludex®-for-the-treatment-of-chronic-hepatitis-D-3673-PIL.pdf

Atezolizumab (1875mg 21-days) SC

Description: Chemotherapy Protocol UROTHELIAL CANCER Atezolizumab SC (1875mg – 21 days) Regimen • Urothelial cancer – Atezolizuma
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Bladdercancer/Atezolizumab-SC-1875mg-21-days.pdf

Capecitabine-Cisplatin-Trastuzumab

Description: Chemotherapy Protocol GASTROINTESTINAL (UPPER) CANCER CAPECITABINE-CISPLATIN-TRASTUZUMAB Regimen • Gastrointestinal (Upper) Cancer –
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Upper-gastro-intestinal/Capecitabine-Cisplatin-Trastuzumab.pdf

Cisplatin-Fluorouracil-Trastuzumab

Description: Chemotherapy Protocol GASTROINTESTINAL (UPPER) CANCER CISPLATIN-FLUOROURACIL-TRASTUZUMAB Regimen • Gastrointestinal (Upper) Cancer – C
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Upper-gastro-intestinal/Cisplatin-Fluorouracil-Trastuzumab.pdf

Chimeric antigen receptor T-cell (CAR-T) therapy discharge medicines - patient information

Description: This factsheet explains what chimeric antigen receptor T-cell (CAR-T) therapy is and what it involves so you know what
Url: /Media/UHS-website-2019/Patientinformation/Cancercare/Chimeric-antigen-receptor-T-cell-CAR-T-therapy-discharge-meds-3635-PIL.pdf

Skin surgery without stitches - patient information

Description: This factsheet contains aftercare advice following skin surgery without stitches.
Url: /Media/UHS-website-2019/Patientinformation/Skin/Skin-surgery-without-stitches-1055-PIL.pdf

Expressing breast milk for your baby - patient information

Description: A guide to expressing breast milk for your baby.
Url: /Media/UHS-website-2019/Patientinformation/Neonatal/Expressing-breast-milk-for-your-baby-3251-PIL.pdf

Standing Financial Instructions

Description: These Standing Financial Instructions (SFIs) are issued for the regulation of the conduct of Trust members and officers in relation to
Url: /Media/UHS-website-2019/Docs/About-the-Trust/Finance/StandingFinancialInstructions.pdf

Vitamin K supplements for newborn babies - patient information

Description: This factsheet explains what vitamin K is, why it is recommended for newborn babies and what your options are when your
Url: /Media/UHS-website-2019/Patientinformation/Pregnancyandbirth/Vitamin-K-supplements-for-newborn-babies-2143-PIL.pdf

AmB LEAM (split)-Lomustine-Cytarabine-Etoposide-Melphalan

Description: Chemotherapy Protocol LYMPHOMA LOMUSTINE-CYTARABINE-ETOPOSIDE (split)-MELPHALAN (LEAM) Ambulatory Regimen This regimen is
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/AmB-LEAM-split-Lomustine-Cytarabine-Etoposide-Melphalan.pdf

391 to 400 of 789

Previous … 38 39 40 41 42 … Next